2017

1. GEIS-21: A multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: A report from the Spanish sarcoma group (GEIS)

   British Journal of Cancer, Vol. 117, Núm. 6, pp. 767-774

2. Gemcitabine plus sirolimus for relapsed and progressing osteosarcoma patients after standard chemotherapy: A multicenter, single-arm phase II trial of Spanish Group for Research on Sarcoma (GEIS)

   Annals of Oncology, Vol. 28, Núm. 12, pp. 2994-2999